1-5 of 5
Laura A. Sena
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB411: Investigating the dependency of androgen receptor-positive prostate cancer on class I myosins

Free
Anoushka Kadam, Shivani Kumar, Varsha Vakkala, Rajendra Kumar, Angelo M. De Marzo, Edward J. Pearce, Laura A. Sena
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB411.
https://doi.org/10.1158/1538-7445.AM2024-LB411
Published: 05 April 2024
View articletitled, Abstract LB411: Investigating the dependency of androgen receptor-positive prostate cancer on class I myosins
Journal Articles

Abstract LB405: CTP synthase 1 is a synthetic vulnerability in prostate cancer treated with supraphysiological androgen

Free
Sheila Jonnatan, Rajendra Kumar, Varsha Vakkala, Karthik Vasan, Zachary R. Chalmers, Daniel R. Schmidt, Philip A. Beer, Matthew G. Vander Heiden, Samuel R. Denmeade, Navdeep S. Chandel, Laura A. Sena
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): LB405.
https://doi.org/10.1158/1538-7445.AM2024-LB405
Published: 05 April 2024
View articletitled, Abstract LB405: CTP synthase 1 is a synthetic vulnerability in prostate cancer treated with supraphysiological androgen
Journal Articles

Abstract A079: Glutamine antagonist prodrug JHU083 reprograms immunosuppressive tumor-associated macrophages to drive tumor immunity in urologic cancers

Free
Monali Praharaj, Fan Shen, Alex J. Lee, Liang Zhao, Thomas R. Nirschl, Xiaoxu Wang, Debebe Theodros, Alok K. Singh, Raekwon A. Williams, Laura A. Sena, Elizabeth A. Thompson, Ada Tam, Srinivasan Yegnasubramanian, Edward J. Pearce, Robert D. Leone, Jesse Alt, Rana Rais, Barbara S. Slusher, Drew M. Pardoll, Jonathan D. Powell, Jelani C. Zarif
Journal: Cancer Research
Cancer Res (2023) 83 (11_Supplement): A079.
https://doi.org/10.1158/1538-7445.PRCA2023-A079
Published: 02 June 2023
View articletitled, Abstract A079: Glutamine antagonist prodrug JHU083 reprograms immunosuppressive tumor-associated macrophages to drive tumor immunity in urologic cancers
Journal Articles

Abstract 6432: Glutamine antagonist prodrug JHU083 reprograms immunosuppressive tumor-associated macrophages (TAMs) to drive tumor immunity in urologic cancers

Free
Monali Praharaj, Fan Shen, Alex J. Lee, Liang Zhao, Thomas Nirschl, Xiaoxu Wang, Debebe Theodros, Alok K. Singh, Raekwon A. Williams, Laura A. Sena, Elizabeth A. Thompson, Ada Tam, Srinivasan Yegnasubramanian, Edward J. Pearce, Robert D. Leone, Jesse Alt, Rana Rais, Barbara S. Slusher, Andrew M. Pardoll, Jonathan D. Powell, Jelani C. Zarif
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6432.
https://doi.org/10.1158/1538-7445.AM2023-6432
Published: 04 April 2023
View articletitled, Abstract 6432: Glutamine antagonist prodrug JHU083 reprograms immunosuppressive tumor-associated macrophages (TAMs) to drive tumor immunity in urologic cancers
Journal Articles

Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?

Open Access
Laura A. Sena, Samuel R. Denmeade
Journal: Cancer Research
Cancer Res (2021) 81 (17): 4385–4393.
https://doi.org/10.1158/0008-5472.CAN-21-1392
Published: 01 September 2021
View articletitled, Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
Open the PDF for Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon? in another window